Eloxx Pharmaceuticals Inc (ELOX)
0.8058
+0.02
(+2.65%)
USD |
OTCM |
Apr 26, 14:39
Eloxx Pharmaceuticals Shareholders Equity (Quarterly): -20.05M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -20.05M |
June 30, 2023 | -18.60M |
March 31, 2023 | -16.29M |
December 31, 2022 | -10.66M |
September 30, 2022 | -4.982M |
June 30, 2022 | 1.812M |
March 31, 2022 | 11.69M |
December 31, 2021 | 22.38M |
September 30, 2021 | 33.00M |
June 30, 2021 | 40.64M |
March 31, 2021 | 2.75M |
December 31, 2020 | 10.23M |
September 30, 2020 | 15.08M |
June 30, 2020 | 20.29M |
March 31, 2020 | 26.26M |
December 31, 2019 | 36.21M |
September 30, 2019 | 45.23M |
June 30, 2019 | 55.22M |
March 31, 2019 | 34.43M |
December 31, 2018 | 42.91M |
September 30, 2018 | 51.46M |
June 30, 2018 | 59.92M |
March 31, 2018 | 13.50M |
September 30, 2017 | 3.315M |
June 30, 2017 | 0.8712M |
Date | Value |
---|---|
March 31, 2017 | 2.585M |
December 31, 2016 | 2.842M |
September 30, 2016 | 3.626M |
June 30, 2016 | 4.561M |
March 31, 2016 | 5.642M |
December 31, 2015 | 8.725M |
September 30, 2015 | 12.51M |
June 30, 2015 | 12.22M |
March 31, 2015 | 11.21M |
December 31, 2014 | 11.94M |
September 30, 2014 | 22.43M |
June 30, 2014 | 27.49M |
March 31, 2014 | 9.805M |
December 31, 2013 | 7.720M |
September 30, 2013 | 2.118M |
June 30, 2013 | 3.786M |
March 31, 2013 | 3.312M |
December 31, 2012 | 1.581M |
September 30, 2012 | 2.629M |
June 30, 2012 | 3.453M |
March 31, 2012 | 4.599M |
December 31, 2011 | 2.833M |
September 30, 2011 | 3.933M |
June 30, 2011 | 4.518M |
March 31, 2011 | 6.899M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-20.05M
Minimum
Sep 2023
55.22M
Maximum
Jun 2019
13.90M
Average
13.38M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.042M |
Total Liabilities (Quarterly) | 26.09M |